PubMedopen access
Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphoma.
humans, lymphoma, follicular, lenalidomide, rituximab, antineoplastic combined chemotherapy protocols, female
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 351945
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.